A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
China
Fujian Cancer Hospital, Fuzhou, Fujian Dongguan People's Hospital, Dongguan, Guangdong Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, Guangzhou The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Zhongnan Hospital of Wuhan University, Wuhan, Hubei Jinan Central Hospital, Jinan, Shandong Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang Age range
18 Years – 75 Years
Last updated September 2025